Sammy L Gorham

Title: The Innovations of Sammy L. Gorham

Introduction

Sammy L. Gorham is an accomplished inventor based in Upper Marlboro, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for the poultry industry, providing innovative solutions to combat infectious diseases.

Latest Patents

Gorham holds a patent for a monoclonal antibody that neutralizes multiple strains of infectious bursal disease in chickens. This invention involves the isolation of monoclonal antibodies from deposited hybridomas, which are effective in preventing the disease by neutralizing various virus strains. The vaccination of an entire poultry population with a vaccine prepared from these antibodies ensures a uniform level of protection against all tested strains. Furthermore, these monoclonal antibodies are effective in inducing priming for an active anti-viral response in a heterologous host.

Career Highlights

Sammy L. Gorham is affiliated with the University System of Maryland, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve poultry health and productivity.

Collaborations

Gorham has collaborated with notable colleagues, including David B. Snyder and Warren W. Marquardt. These partnerships have contributed to the success and impact of his research in the field.

Conclusion

Sammy L. Gorham's contributions to biotechnology through his innovative patent on monoclonal antibodies highlight his role as a significant inventor in the industry. His work not only addresses critical health issues in poultry but also showcases the importance of research and collaboration in advancing scientific knowledge.